Avid Radiopharmaceuticals
Marybeth Devine has a strong background in clinical imaging operations and program management. Marybeth started their career as a Clinical Specialist at DuPont Merck Pharmaceutical Company in 1993 and later became a Clinical Program Manager at DuPont Pharmaceuticals. Marybeth joined Bristol-Myers Squibb Medical Imaging in 2002 as a Sr. Clinical Program Manager and then moved to Lantheus Medical Imaging in 2008 as an Associate Director of Clinical Programs. In 2011, Marybeth joined Avid Radiopharmaceuticals as the Director of Clinical Imaging Operations, and later served as the Sr. Director and Associate VP in the same field. Their extensive experience spans over 25 years in the healthcare industry.
Marybeth Devine attended The Ohio State University from 1981 to 1987, where they obtained a Bachelor of Science (BS) degree in Allied Health. Marybeth then pursued further education at The Ohio State University from 1988 to 1989 and obtained a Bachelor of Science (BS) degree in Nuclear Medicine. Later, in 2006 and 2007, they attended Kaplan University for Graduate Studies in Project Management; however, the degree obtained in this time period is not specified.
This person is not in any offices
Avid Radiopharmaceuticals
1 followers
At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avid's pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages of pathological change; allowing early treatment and management of people at risk - perhaps before before symptoms of disease can develop.